Our editorial approach
Built around traceable context
We organize information so readers can distinguish between reported experience, preliminary findings, established guidance, and open questions. Where possible, our approach begins with registries, published literature, and official materials rather than promotional claims.
That distinction matters because a scientific study is designed to test a question under stated conditions. The ClinicalTrials.gov study registry is one useful place to inspect how research questions are framed, while the PubMed literature database helps readers locate biomedical publications directly.
Our wayfinding and topic guides are organized to support slower review: evidence, safety, access, and practical questions are kept distinct so uncertainty is not blurred into certainty.
- 01Independence. We keep the resource separate from treatment provision and sales claims.
- 02Evidence before hype. We prioritize attributable sources and clear limits.
- 03Safety awareness. We do not minimize risk or present information as a substitute for professional care.
- 04Plain language. We use accessible terms without flattening important nuance.
- 05Respect for uncertainty. We say when an answer is incomplete, contested, or unavailable.